Prior Authorization and Future Applications (from the Radiopharmaceutical Therapy Curriculum Series)

Prior Authorization and Future Applications (from the Radiopharmaceutical Therapy Curriculum Series) is organized by American Society for Radiation Oncology (ASTRO).

Course opens: 07/19/2024
Course expires: 07/04/2026

Description:
The content was originally presented and recorded on June 28, 2024, in the Beyond the Beam: A Radiation Oncology Curriculum for Radiopharmaceutical Therapy webinar series. Beyond the Beam is a 15-hour in-depth curriculum that is designed specifically for radiation oncology residents and practicing radiation oncologists who are planning or participating in a radiopharmaceutical therapy (RPT) clinical program. The course broadly covers the topics recommended for RPT education by the International Atomic Energy Agency and the Nuclear Regulatory Commission, including physics, radiobiology, chemistry, molecular imaging, dosimetry, radiation protection, regulatory issues, quality and safety, and therapy-specific considerations of the above for PSMA-targeted agents, Ra-223, RAI, Lu-DOTATE, liver-directed RPT, and other agents.

Learning Objectives:
Upon completion of this activity, participants should be able to:

• Identify novel applications of radiopharmaceutical therapies.
• Increase awareness of future directions in radiopharmaceutical therapies.
• Describe the process of becoming an authorized user.

Topics Covered:
Miscellaneous and Future Applications of Radiopharmaceutical Therapy – How To Become an Authorized User, Meta-iodobenzylguanidine, Rhenium Skin Cancer Therapy, Radiosynoviorthesis, Alpha Emitters, Other
- Michael Folkert, MD, PhD

For more information, please see the Program tab.